| NeoGenomics Reports First Quarter Results (PR Newswire) NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services today reported its results for the first quarter 2010. us.rd.yahoo.com |
Meeting Held by Mylan Being Probed The SEC is investigating whether the generic-drug maker disclosed confidential information about coming earnings, allowing participants to snap up shares before a big rally. online.wsj.com |
MEDTOX Scientific Announces Strong Second Quarter Results (GlobeNewswire) ST. PAUL, Minn. -- MEDTOX Scientific, Inc. today announced results for the second quarter ended June 30, 2010. MEDTOX achieved a significant increase in new clinical laboratory business for the quarter ended June 30, 2010, and laboratory drugs-of-abuse testing showed a net positive increase in revenues of 5.6% for the second quarter of 2010, compared to a decrease of 10.6% in the prior year quarter: us.rd.yahoo.com |
Pfizer Acts on Growing Interest in Niche Drugs The Burrill Report submits: By Michael FitzhughPfizer (PFE) has agreed to by FoldRX, a privately held specialty drug developer targeting protein misfolding for an undisclosed initial payment plus milestones. The purchase builds on the drug giant's growing interest in niche drugs, a category it has begun to develop as a potential source of new revenues capable of partially stemming the losses it will incur when Lipitor goes off-patent in 2011. Complete Story » seekingalpha.com |
Avanir Trading Volatility and Increased Short Interest in September Provides Promising Opportunity Sheff Station submits:AVNR could end up being the most volatile stock of all the biotech stocks up for approval during October into their Oct 30th PDUFA date. This will provide trading opportunities for investors and also have the opportunity for the most promising gains. AVNR investors saw their stock trade as low as $2.64 on 9/16. One of the reasons for this could potentially be attributed to the significant increase in short position from 8/31 to 9/15. During that period the percent increase in short position at the end of 9/15 was 37%. That was an increase of 26% from an 11% increase at the start of 8/31. From 8/31 to 9/15 the short increase was almost 3 million shares (2.83 mill) from 7.64 million to 10.48 million. click to enlarge Complete Story » seekingalpha.com |